Rockefeller Capital Management »

Inmune Bio Ord shares owned by Rockefeller Capital Management

Quarter-by-quarter ownership of Inmune Bio Ord (INMB) shares owned by Rockefeller Capital Management from 13F filings

Historical chart of Rockefeller Capital Management investment in Inmune Bio Ord

Tip: Access up to 7 years of quarterly data

All positions including Inmune Bio Ord held by Rockefeller Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inmune Bio Ord by Rockefeller Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $205k 18k 11.26
2020-06-30 $0 50 0.00

More positions owned by Rockefeller Capital Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)

View all positions for Rockefeller Capital Management

Top funds holding Inmune Bio Ord

Vanguard Group
Janney Montgomery Scott
Deutsche Bank Aktiengesellschaft
MAI Wealth Advisors
Quadrant Capital
Royal Bank of Canada
Citadel Advisors
UBS Group
Jane Street
Citigroup
Westside Investment Management
Fermata Advisors
Bank of New York Mellon
Millennium Management
Balyasny Asset Management

View all funds holding Inmune Bio Ord